Biomarkers used to predict recurrent disease in hepatitis C transplant patients

Posted: 5-Oct-2005 << BACK

Two new studies on Hepatitis C (HCV) patients who underwent liver transplants examined a potential biomarker that could be used to predict who might develop hepatic fibrosis, a formation of scar-like tissue that can lead to cirrhosis. The studies found that changes in a certain type of liver cell were useful in determining those who were at the greatest risk for developing this serious complication....to read the article click here